HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by de Cremoux, P. Articles by Raffin-Sanson, M.-L. Search for Related Content PubMed PubMed Citation Articles by de Cremoux, P. Articles by Raffin-Sanson, M.-L.

¹ Unité de Pharmacologie, Institut Curie, 26 rue d'Ulm, 75005 Paris, France² Ecole Nationale Vétérinaire d'Alfort, 94704 Maisons-Alfort Cedex, France³ Laboratoire d'Oncobiologie, Centre Francois Baclesse, Caen, France⁴ Department of Pathology⁵ Department of Endocrinology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France⁶ Department of Endocrinology, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, 9 Av Charles de Gaulle, Boulogne 92100, France⁷ Faculté de Médecine Paris-Ile de France Ouest, Université de Versailles SQY, Versailles, France⁸ INSERM, U567, Paris F-75014, France⁹ Département d'Endocrinologie Métabolisme and Cancer, Institut Cochin, Paris F-75014, France¹⁰ CNRS, UMR8104, Paris F-75014, France¹¹ Faculté de Médecine René Descartes, Université Paris 5, Paris F-75014, France

(Correspondence should be addressed to M-L Raffin-Sanson, Department of Endocrinology, Hôpital Ambroise Paré, 9 Av Charles de Gaulle, Boulogne, 92100, France; Email: marie-laure.raffin-sanson{at}apr.aphp.fr)

Adrenal tumors occur more frequently in women and are the leading cause of Cushing's syndrome during pregnancy. We aimed to evaluate the potential role of sex steroids in the susceptibility of women to adrenocortical tumors. We evaluated the presence of the progesterone receptor (PR), estradiol receptors (ERs), and aromatase in 5 patients with primary pigmented nodular adrenal disease (PPNAD), 15 adrenocortical adenomas (ACAs) and adjacent normal tissues, 12 adrenocortical carcinomas (ACCs), and 3 normal adrenal glands (NA). The expression of PR and ER was evaluated by enzyme immunoassays, real-time RT-PCR, immunohistochemistry, and cytosol-based ligand-binding assays. ERβ and aromatase levels were evaluated by real-time RT-PCR. ER concentrations were low in NA, in adrenal tissues adjacent to ACA (51±33), in ACC (53±78), and lower in ACA (11±11 fmol/mg DNA). Conversely, PR concentrations were high in NA and adrenal tissues adjacent to ACA, at 307±216 fmol/mg DNA, and were even higher in tumors – 726±706 fmol/mg DNA in ACA and 1154±1586 fmol/mg DNA in ACC – and in isolated PPNAD nodules. Binding study results in four tumors were compatible with binding to a steroid receptor. In patients with PPNAD, a strong positive immunohistochemical signal was associated with the sole isolated nodular regions. ERβ transcript levels were very high in all samples except those for two ACCs, whereas aromatase levels were low. PR and ERβ are clearly present in normal adrenal glands and adrenal tumors. Further studies may shed light on the possible pathogenic role of these receptors in adrenal proliferation.